Showing results (3041-3050 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1995
A phase II clinical trial of echinomycin in metastatic soft tissue sarcoma. An Illinois Cancer Center StudyW J Gradishar, N J Vogelzang, L J Kilton, et al.Investigational New Drugs|January 1, 1995
A phase II trial of paclitaxel (Taxol) as first line treatment in advanced breast cancerS M Swain, S F Honig, M C Tefft, et al.Investigational New Drugs|January 1, 1995
Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract (UGIT). The Eastern Cooperative Oncology group (ECOG) resultsA I Einzig, S Lipsitz, P H Wiernik, et al.Investigational New Drugs|January 1, 1995
Didemnin B in favourable histology non-Hodgkin's lymphoma. A phase II study of the National Cancer Institute of Canada Clinical Trials GroupG Goss, A Muldal, R Lohmann, et al.Investigational New Drugs|January 1, 1995
Cutaneous manifestations of Taxol therapyC J Link, G A Sarosy, E C Kohn, et al.Investigational New Drugs|February 1, 2006
A phase II study of chloroquinoxaline sulfonamide (CQS) in patients with metastatic colorectal carcinoma (MCRC)Tanios S Bekaii-Saab, Amir Mortazavi, Lee G Hicks, et al.Investigational New Drugs|January 1, 1996
Pediatric drug development: a perspective from the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI)M Smith, P T HoInvestigational New Drugs|January 1, 1996
The importance of phase I/II trials in pediatric oncologyC A MacArthur, T ViettiInvestigational New Drugs|December 16, 1998
Chronic effects of a novel synthetic anthracycline derivative (SM-5887) on normal heart and doxorubicin-induced cardiomyopathy in beagle dogsT Noda, T Watanabe, A Kohda, et al.Investigational New Drugs|December 16, 1998
Phase II trial of oral beta-all trans-retinoic acid in hepatocellular carcinoma (SWOG 9157)F L Meyskens, J Jacobson, B Nguyen, et al.Pageof 372